Merck KGaA to Invest EUR59 Million to Expand Pharmaceutical Manufacturing at US Facility
September 09 2020 - 11:10AM
Dow Jones News
By Cecilia Butini
Merck KGaA said Wednesday that it would invest 59 million euros
($69.5 million) in expanding its manufacturing capabilities, and
capacity for high-potent active pharmaceutical ingredients and
antibody-drug conjugates at its U.S. facility near Madison,
Wisc.
The German pharmaceuticals and chemicals company said the
investment would allow manufacturing of compounds for therapies
which have the potential to treat cancer, and it would create
roughly 50 full-time jobs starting in 2021.
Completion of the expansion--which consists of a
6,500-square-meter commercial building--is expected by mid-2022,
the company said.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
September 09, 2020 10:55 ET (14:55 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Apr 2023 to Apr 2024
